About Us
Our Business
Investors
Media
Community
Sustainability
Careers
Contact
Menu
India
USA
UK
South Africa
Australia
Philippines
Germany
Netherlands
Mexico
Brazil
Canada
Switzerland
Close
About Us
Overview
The Lupin Story
Our Purpose
Our Values
Our Leadership
Compliance, Ethics and Governance
Global Presence
Our Manufacturing Approach
Quality in Action
Our Science
Awards and Recognitions
Our Business
Overview
Global Generics
Emerging Markets
India
Specialty and Innovation
Biosimilars
Our Adjacencies
Investors
Overview
Financial Reporting
Financial Information
Quarterly Results
Integrated Report
Financial Statements of Subsidiaries
Corporate Governance
Our Leadership
Committees of the Board
Code of Conduct
Policies
MOA and AOA
Shareholder Information
Stock Exchange Intimations
AGM, Postal Ballot, and EGM
Shareholding Pattern
Share Price
Ratings
Dividend
Unclaimed Dividend and Shares
Employee Stock Option Schemes
Important Communication for Shareholders
Investor FAQs
Investor Contacts
News and Events
Press Releases
Presentations
Disclosure Under Regulation 46 of SEBI (LODR) Regulations, 2015
Media
Overview
Press Releases
Media Coverage
Perspectives
Media Kit
Community
Sustainability
Overview
ESG Framework
ESG Goals and Progress
Key Highlights
ESG Ratings
ESG Governance
Careers
Contact
About Us
Our Business
Investors
Media
Community
Sustainability
Careers
Contact
Overview
The Lupin Story
Our Purpose
Our Values
Our Leadership
Compliance, Ethics and Governance
Global Presence
Our Manufacturing Approach
Quality in Action
Our Science
Awards and Recognitions
+91 22 6640 2323
info@lupin.com
Financial
Reporting
Financial Information
Quarterly Results
Integrated Report
Financial Statement of Subsidiaries
Financial Statement of Subsidiaries
FY2024-25
FY2023-24
FY2022-23
FY2021-22
FY2020-21
FY2019-20
FY2018-19
FY2017-18
Avenue Coral Springs, LLC (w.e.f. November 29, 2021)
Generic Health Pty Ltd., Australia
Generic Health SDN. BHD., Malaysia
Hormosan Pharma GmbH, Germany
Laboratorios Grin, S.A. de C.V., Mexico
Lupin Atlantis Holdings SA, Switzerland
Lupin Australia Pty Ltd., Australia
Lupin Biologics Limited, India (w.e.f January 28, 2021)
Lupin Diagnostics Limited, India (formerly known as Lupin Healthcare Limited)
Lupin Digital Health Limited, India (w.e.f. May 21, 2021
Lupin Europe GmbH, Germany ( w.e.f. February 5, 2018)
Lupin Foundation
Lupin Healthcare (UK) Ltd (Formerly known as Lupin (Europe) Limited, UK)
Lupin Inc., USA.
Lupin Lanka (Private) Ltd., Sri Lanka
Lupin Life Sciences Limited (formerly known as Lupin Atharv Ability Limited)
Lupin Management, Inc., USA (earlier known as Lupin IP Ventures Inc., USA) (w.e.f. October 10, 2017)
Lupin Manufacturing Solutions Limited (w.e.f. July 24, 2023)
Lupin Mexico S.A. de C.V., Mexico
Lupin NZ Ltd., New Zealand
Lupin Oncology Inc., USA (w.e.f March 15, 2021)
Lupin Pharma Canada Ltd., Canada
Lupin Pharmaceuticals, Inc., USA.
Lupin Philippines, Inc., Philippines
Lupin Research Inc., USA.
Medisol S.A.S., France (w.e.f. September 1, 2023)
Medquimica Industria Farmaceutica LTDA, Brazil
Multicare Pharmaceuticals Philippines, Inc., Philippines
Nanomi B.V., Netherlands (earlier known as Lupin Holdings B.V., Netherlands)
Novel Laboratories, Inc., USA.
Pharma Dynamics (Proprietary) Ltd., South Africa
Southern Cross Pharma Pty Ltd., Australia (w.e.f. February 3, 2022)
YL Biologics Ltd., Japan (Joint Venture)
Product Finder
